Experimental Biology and Medicine

Exploring the frontiers of biology, medicine, and engineering to advance human health. Peer-reviewed. Global.
Official journal of @SocExpBioMed

[Experimental Biology and Medicine @ExpBiolMed]

❤️ Could antibodies against viruses influence heart disease risk?
A Mendelian randomization study found potential causal links between antibody levels against several viruses and cardiovascular conditions, including myocarditis and aortic valve stenosis.
🔬 https://t.co/s9YuWYNMlX

[Experimental Biology and Medicine @ExpBiolMed]

🧠 Could blood tests help improve ALS diagnosis?
A study in Experimental Biology and Medicine found that combining four blood measures related to immune cells and blood sugar, showed greater diagnostic value than any single measure.
🔬 https://t.co/TCh096hYU7

[BioCore: A Scholarly Publishing Consortium @BioCore_Pubs]

🔬 Thank you to everyone who joined BioCore at King's College London on Oct 19!

From scientific talks and publishing discussions to dinner with local researchers, we enjoyed connecting with the research community.

Special thanks to our editors:
🔹 Daniel G. Remick, MD — @TheShockJournalk
🔹 Nicola Conran, PhD — @ExpBiolMed
🔹 Aleksandar Rajkovic, MD, PhD — @BiolReprod
🔹 Michael N. Lehman, PhD — Journal of Neuroendocrinology

[Experimental Biology and Medicine @ExpBiolMed]

🧪 Researchers developed a seven-chamber human liver model that supports more experiments while preserving key features of liver biology. Published in Experimental Biology and Medicine, the platform also reproduces features of MASLD, supporting future liver disease and drug research.
🔗 Read the study:
https://t.co/Cl9pZ9wIaH

[Experimental Biology and Medicine @ExpBiolMed]

❤️ High systolic blood pressure was the leading risk factor contributing to the U.S. stroke burden in 2021, according to a study in Experimental Biology and Medicine. The findings highlight the importance of blood pressure management in stroke prevention. 🔗 Read the study:
https://t.co/Zz9vO3XbjP

[Experimental Biology and Medicine @ExpBiolMed]

🫁 What role could NOX4 play in lung disease?
A new review in Experimental Biology and Medicine examines how this enzyme may contribute to inflammation, cell death, oxygen sensing, and metabolic changes across diseases including pulmonary fibrosis, COPD, asthma, ARDS, and pulmonary hypertension.
The review also explores NOX4 as a potential therapeutic target while highlighting challenges such as specificity and off-target effects.
🔗 Read the review:
https://t.co/sHP9Wk9A1F

[Experimental Biology and Medicine @ExpBiolMed]

New drug leads for African trypanosomiasis? 🔬
A study in Experimental Biology and Medicine found that two Pathogen Box compounds showed selective activity against bloodstream-form Trypanosoma brucei brucei in the lab.
The compounds were linked to cell-death features, cell-cycle disruption, and mitochondrial stress. Further testing is needed in human-infective parasites and animal models.
Read the open-access article:
https://t.co/W1fnWl7XUd

[Experimental Biology and Medicine @ExpBiolMed]

🦷 New at EBM: Oral Biology and Disease

We’re pleased to welcome Dr. Poliana Duarte (@UF) as Associate Editor leading this new category exploring the biology of oral health and disease.

Now open for submissions: https://t.co/eeu1pDaerm

[Experimental Biology and Medicine @ExpBiolMed]

📢 Call for Papers from Experimental Biology and Medicine (EBM)

EBM is seeking Reviews and Mini-Reviews exploring how disease mechanisms can drive advances in therapeutics, biomarkers, prevention, and precision medicine.

Explore the focused issue & submit your research: https://t.co/6EaucgrXyt

[Frontiers Publishing Partnerships @FrontPartners]

Big news for @ExpBiolMed! 🎉

The 2026 Journal Impact Factor is 3.8 and the CiteScore has reached 6.6.

Thank you to every author, reviewer, and editor who contributed.

📖 Explore the full metrics: https://t.co/S0DYvZJkPC

#JournalImpactFactor #BiomedicalScience #OpenAccess

[Experimental Biology and Medicine @ExpBiolMed]

📈 Big news from Experimental Biology and Medicine!

EBM's 2025 Impact Factor increased to 3.8 (+40% from last year).

Also we're proud to share other metrics that show the impact of our journal:
🔹 5-Year IF: 4.0
🔹 CiteScore: 6.6

Thank you to our authors, reviewers, editors, and readers for making this possible!

[Experimental Biology and Medicine @ExpBiolMed]

📈 Big news from Experimental Biology and Medicine!

EBM's 2025 Impact Factor increased to 3.8 (+40% from last year).

Also we're proud to share other metrics that show the impact of our journal:
🔹 5-Year IF: 4.0
🔹 CiteScore: 6.6

Thank you to our authors, reviewers, editors, and readers for making this possible!

[Frontiers Publishing Partnerships @FrontPartners]

📢 Applications are open for the inaugural @ExpBiolMed #EarlyCareerResearcher Editorial Board!

🔬 Peer review experience
🤝 Mentorship from Associate Editors
🌐 A global biomedical network

Deadline: July 15, 2026

Apply now → https://t.co/blam0HtzYs

[Frontiers Publishing Partnerships @FrontPartners]

Vol. 251, Issue 4 of Experimental Biology and Medicine is out! 🔬

Explore the latest research spanning neuroscience, cancer biology, cardiology, and more in @ExpBiolMed.

https://t.co/Ap1i9fqOcK

#ExperimentalBiologyAndMedicine #BiomedicalResearch #OpenAccess

[Experimental Biology and Medicine @ExpBiolMed]

Ready to expand your impact beyond the lab?

Join the inaugural Experimental Biology and Medicine Early Career Researcher Editorial Board and gain hands-on experience in peer review, editorial decision-making, publishing ethics, and research integrity.

📅 Deadline: July 15, 2026
Learn more and apply: https://t.co/AY6qi6egym

[Experimental Biology and Medicine @ExpBiolMed]

🔬 New issue out now: Experimental Biology and Medicine Volume 251, Issue 4

This month’s issue features multidisciplinary biomedical research covering:
🫀 Cardiotoxicity & oxidative stress
🧠 Biomarkers in subarachnoid hemorrhage
🧬 Neuroblastoma-targeting phytometabolites
🚬 Thirdhand smoke exposure
🩺 Neuropathic pain therapies
🔍 Translational research trends

Plus studies in melanoma, diabetic wound healing, and more: https://t.co/KQ4BpDDUSU

#BiomedicalResearch #ExperimentalBiology #Medicine

[Experimental Biology and Medicine @ExpBiolMed]

🔬 Call for Papers: Inflammasomes as Therapeutic Targets

Submit your research to Experimental Biology and Medicine on inflammation, neurodegeneration, biomarkers & emerging therapies.

Submit now: https://t.co/138telt5u4

[Experimental Biology and Medicine @ExpBiolMed]

Garlic oil — improved 🧄🧄🧄

By packaging garlic oil in liposomes, researchers boosted its stability and effectiveness. In mice with acute lung injury, it reduced inflammation and lung damage more than garlic oil alone.

Explore one of the latest issue's highlighted article: https://t.co/aJ36mrz8Qr

[Experimental Biology and Medicine @ExpBiolMed]

Heading to #2026SOT in San Diego?
Stop by Booth 2250 to meet Experimental Biology and Medicine (EBM) & @SocExpBioMed 👋

✔ Multidisciplinary biomedical research
✔ Toxicology & beyond
✔ Chat with editors + learn how to submit

See you there! 🔬

[Experimental Biology and Medicine @ExpBiolMed]

Could a protein predict colorectal cancer relapse?

Higher PVR levels were linked to a 2x greater risk of recurrence. Researchers also identified natural compounds that may block PVR activity — pointing to new therapeutic possibilities.

Read one of the latest issue's highlighted articles: https://t.co/eklP8Oopj4